Search Result "1-phenyl-2-decanoylamino-3-morpholino-1-propanol"
P-Glycoprotein Is Not a Key Target for the Chemosensitizing Effect of 1-Phenyl-2-Decanoylamino-3-Morpholino-1-Propanol in HepG2 Cells Exposed to Doxorubicin
Journal: Drug Metabolism Letters
Volume: 4 Issue: 1 Year: 2010 Page: 39-44
Author(s): Sabrina Di Bartolomeo, Paolo Luly, Angelo Spinedi
Agents for the Treatment of Glycosphingolipid Storage Disorders
Journal: Current Drug Metabolism
Volume: 2 Issue: 3 Year: 2001 Page: 331-338
Author(s): A. Abe, S. R. Wild, L. Lee, J. A. Shayman
Relevance of the Salvage Pathway to N-Hexanoylsphingosine Metabolic Downregulation in Human Neurotumor Cells: Implications for Apoptosis
Journal: Drug Metabolism Letters
Volume: 6 Issue: 1 Year: 2012 Page: 60-66
Author(s): Angelo Spinedi
A Role for Lysosomal Phospholipase A2 in Drug Induced Phospholipidosis
Journal: Drug Metabolism Letters
Volume: 1 Issue: 1 Year: 2007 Page: 49-53
Author(s): Akira Abe, Miki Hiraoka, James A. Shayman
Fine Tuning Therapeutic Targeting of the Sphingolipid Biosynthetic Pathway to Treat Atherosclerosis
Journal: Current Vascular Pharmacology
Volume: 4 Issue: 2 Year: 2006 Page: 151-154
Author(s): W. S. Kim, Charles E. Chalfant, Brett Garner
Sphingolipid Metabolism Enzymes as Targets for Anti-Cancer Therapy
Journal: Current Drug Targets
Volume: 5 Issue: 4 Year: 2004 Page: 375-382
Author(s): J. W. Kok, H. Sietsma
Bioactives in Disease Prevention and Health Promotion: Exploiting Combinatorial Effects
Journal: Current Bioactive Compounds
Volume: 17 Issue: 4 Year: 2021 Page: 299-317
Author(s): Sunil C. Gurumallu,Rajesha Javaraiah
Sphingolipid Metabolism and Drug Resistance in Hematological Malignancies
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11 Issue: 9 Year: 2011 Page: 891-903
Author(s): Valerie Gouaze-Andersson, Myles C. Cabot
Pharmacological Modulation of Sphingolipids and Role in Disease and Cancer Cell Biology
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7 Issue: 4 Year: 2007 Page: 371-382
Author(s): Albert Morales, Jose C. Fernandez-Checa
Miglustat: Substrate Reduction Therapy for Lysosomal Storage Disorders Associated with Primary Central Nervous System Involvement
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 1 Issue: 1 Year: 2006 Page: 77-82
Author(s): Gregory M. Pastores